Diagnostic cholangiopancreatography

Endoscopy

Volumn 35, Issue 2, 2003, Pages 145-155

  Schöfl, Rainer ^a   Haefner, M ^b  

^a St Elizabeth's Hospital   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; DIAZEPAM; GLUCAGON; GLYCERYL TRINITRATE; HEPARIN; HYDROCORTISONE; INTERLEUKIN 10; MIDAZOLAM; OCTREOTIDE; PREDNISONE; XANTHINE OXIDASE INHIBITOR;

CHRONIC PANCREATITIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXPERIMENTAL MODEL; HEADACHE; HEPATOBILIARY DISEASE; HUMAN; HYPOTENSION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MANOMETRY; MEDICAL DECISION MAKING; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PANCREAS DISEASE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; MAGNETIC RESONANCE IMAGING; MANOMETRY; PANCREATIC DISEASES; POSTOPERATIVE COMPLICATIONS; SENSITIVITY AND SPECIFICITY;

EID: 0037312803     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37017     Document Type: Review

References (56)

1. Menon K, Barkun AN, Romagnuolo J et al. Patient satisfaction after MRCP and ERCP. Am J Gastroenterol 2001; 96: 2646-2650
2. Farrell RJ, Noonan N, Mahmud N et al. Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain. Endoscopy 2001; 33: 668-675
3. Sahai AV, Devonshire D, Yeoh KG et al. The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96: 2074-2080
4. Rösch T, Meining A, Frühmorgen S et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002; 55: 870-876
5. Urban M, Holzer B, Sebesta C et al. Efficacy of diagnosis of mechanical cholestasis by magnetic resonance cholangiography. World J Surg 2002; 26: 353-358
6. Taylor AC, Little AF, Hennessy OF et al. Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc 2002; 55: 17-22
7. Laokpessi A, Bouillet P, Sautereau D et al. Value of magnetic resonance cholangiography in the preoperative diagnosis of common bile duct stones. Am J Gastroenterol 2001; 96: 2354-2359
8. Lopera JE, Soto J, Munera F. Malignant hilar and perihilar biliary obstruction: Use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 2001; 220: 90-96
9. Harewood GC, Baron TH. Cost analysis of magnetic resonance cholangiography in the management of inoperable hilar biliary obstruction. Am J Gastroenterol 2002; 97: 1152-1158
10. Chaudhary A, Negi SS, Puri SK, Narang P. Comparison of magnetic resonance cholangiography and percutaneous transhepatic cholangiography in the evaluation of bile duct strictures after cholecystectomy. Br J Surg 2002; 89: 433-436
11. Calvo MM, Bujanda L, Calderon A et al. Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct. Am J Gastroenterol 2002; 97: 347-353
12. Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M. Pancreatic duct: Morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 2002; 222: 674-680
13. Varghese JC, Masterson A, Lee MJ. Value of MR pancreatography in the evaluation of patients with chronic pancreatitis. Clin Radiol 2002; 57: 393-401
14. Izuishi K, Nakagohri T, Konishi M et al. Spatial assessment by magnetic resonance cholangiopancreatography for preoperative imaging in patial pancreatic head resection. Am J Surg 2001; 182: 188-191
15. Kodama T, Koshitani T, Sato H et al. Electronic pancreatoscopy for the diagnosis of pancreatic diseases. Am J Gastroenterol 2002; 97: 617-622
16. Koito K, Namieno T, Hirokawa N et al. Virtual CT cholangioscopy: Comparison with fiberoptic cholangioscopy. Endoscopy 2001; 33: 676-681
17. Seitz U, Freund J, Jaeckle S et al. First in vivo optical coherence tomography in the human bile duct. Endoscopy 2001; 33: 1018-1021
18. Poneros JM, Tearney GJ, Shiskov M et al. Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc 2002l 55: 84-88
19. Van Heek NT, Rauws EA, Caspers E et al. Long-term follow-up of patients with a clinically benign extrahepatic biliary stenosis and K-ras mutation in endobiliary brush cytology. Gastrointest Endosc 2002; 55: 883-888
20. Boadas J, Mora J, Urgell E et al. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol 2001; 13: 1153-1159
21. O'Mahony S, Sreedharan A. Does detection of K-ras mutations in pancreatic juice influence clinical decision-making? Eur J Gastroenterol Hepatol 2001; 13: 1141-1142
22. Pugliese V, Pujic N, Saccomanno S et al. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: Cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001; 54: 595-599
23. Farrell RJ, Jain AK, Brandwein SL et al. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 2001; 54: 587-594
24. Fazel A, Burton FR. The effect of midazolam on the normal sphincter of Oddi: A controlled study. Endoscopy 2002; 34: 78-81
25. Fazel A, Burton FR. A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility. Gastrointest Endosc 2002; 55: 637-640
26. Quallich LG, Stern MA, Rich M et al. Bile duct crystals do not contribute to sphincter of Oddi dysfunction. Gastrointest Endosc 2002; 55: 163-166
27. Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: An unrecognized entity. Gastrointest Endosc 2002; 55: 427-430
28. Rosenblatt ML, Catalano MF, Alcocer E, Geenen JE. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. Gastrointest Endosc 2001; 54: 697-704
29. Cohen ME, Slezak L, Wells CK et al. Prediction of bile duct stones and complications in gallstone pancreatitis using early laboratory trends. Am J Gastroenterol 2001; 96: 3305-3311
30. Kohut M, Nowak A, Nowakowska-Dulawa E et al. The frequency of bile duct crystals in patients with presumed biliary pancreatitis. Gastrointest Endosc 2001; 54: 37-41
31. Kaw M, Brodmerkel GJ Jr. ERCP, biliary crystal analyis and sphincter of Oddi manometry in idiopathic recurrent pancreatitis. Gastrointest Endosc 2002; 55: 157-162
32. Levy MJ. The hunt for microlithiasis in idiopathic acute recurrent pancreatitis: Should we abandon the search or intensify our efforts? Gastrointest Endosc 2002; 55: 286-293
33. Kim JE, Lee JK, Lee KT et al. The clinical significance of common bile duct dilatation in patients without biliary symptoms or causative lesions on ultrasonography. Endoscopy 2001; 33: 495-500
34. Kama NA, Atli M, Doganay M et al. Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones. Surg Endosc 2001; 15: 942-945
35. Christoforidis E, Goulimaris I, Kanellos I et al. The role of juxtapapillary duodenal diverticula in biliary stone disease. Gastrointest Endosc 2002; 55: 543-547
36. Zoepf T, Zoepf DS, Arnold JC et al. The relationship between juxtapapillary duodenla diverticula and disorders of the biliopancreatic system: Analysis of 350 patients. Gastrointest Endosc 2001; 54; 56-61
37. Nomura T, Shirai Y, Sandoh N et al. Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts. Gastrointest Endosc 2002; 55: 204-208
38. Kim HJ, Kim MH, Lee SK et al. Normal structure, variations, and anomalies of the pancreaticobiliary ducts of Koreans: A nationwide cooperative prospective study. Gastrointest Endosc 2002; 55: 889-896
39. Wilcox CM. Endoscopic examination with the duodenoscope at ERCP: Frequency of lesions and accuracy of detection. Gastrointest Endosc 2002; 55: 538-542
40. Horiuchi A, Kawa S, Hamano H et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002; 55: 494-499
41. Park JS, Kim MH, Lee SK et al. The clinical significance of papillitis of the major duodenal papilla. Gastrointest Endosc 2002; 55: 877-882
42. Ahuja V, Garg PK, Kumar D et al. Presence of white bile associated with lower survival in malignant biliary obstruction. Gastrointest Endosc 2002; 55: 186-191
43. Johlin FC, Pelsang RE, Greenleaf M. Phantom study to determine radiation exposure to medical personnel involved in ERCP fluoroscopy and its reduction through equipment and behavior modifications. Am J Gastroenterol 2002; 97: 893-897
44. Campbell N, Sparrow K, Fortier M, Ponich T. Practical radiation safety and protection for the endoscopist during ERCP. Gastrointest Endosc 2002; 55: 552-557
45. Rabenstein T, Roggenbuck S, Framke B et al. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002; 55: 476-483
46. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: New momentum. Endoscopy 2002; 34: 325-329
47. Dumot JA, Conwell DL, Zuccaro G Jr et al. A randomized, double-blind study of interleukin-10 for the prevention of ERCP-iduced pancreatitis. Am J Gastroenterol 2001; 96: 2098-2102
48. Devière J, Le Moine O, Van Laethem JL et al. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505
49. Budzynska A, Marek T, Nowak A et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001; 33: 766-772
50. Manolakopoulos, S, Avgerinos A, Vlachogiannakos J et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomised controlled trial. Gastrointest Endosc 2002; 55: 470-475
51. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001; 88: 1178-1182
52. Friedland S, Soetikno RM, Vandervoort J et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 2002; 34: 483-488
53. Kaw M, Singh S. Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis. Gastrointest Endosc 2001; 54: 435-440
54. Akashi R, Kiyozumi T, Tanaka T et al. Mechanism of pancreatitis caused by ERCP. Gastrointest Endosc 2002; 55: 50-54
55. Christoforidis E, Goulimaris I, Kanellos I et al. Post-ERCP pancreatitis and hyperamylasemia: Patient-related and operative risk factors. Endoscopy 2002; 34: 286-292
56. Freeman ML, DiSario JA, Nelson DB et al. Risk of post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001; 54: 425-434